Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Full House Resorts
FLL
$80.1M
| $481K | ﹤0.01% |
39,713
+26,343
| +197% | +$285K |
|
|
ESPR
3202
DELISTED
Esperion Therapeutics
ESPR
| $480K | ﹤0.01% |
95,698
+47,092
| +97% | +$377K |
|
3203
Omega Flex
OFLX
$297M
| $479K | ﹤0.01% |
3,766
+2,479
| +193% | +$329K |
|
3204
NGL Energy Partners
NGL
$2.05B
| $478K | ﹤0.01% |
262,706
-810,208
| -76% | -$1.81M |
|
|
ALBO
3205
DELISTED
Albireo Pharma Inc
ALBO
| $477K | ﹤0.01% |
20,480
+13,523
| +194% | +$360K |
|
|
AMNB
3206
DELISTED
American National Bankshares Inc
AMNB
| $477K | ﹤0.01% |
12,689
+8,352
| +193% | +$309K |
|
3207
Willdan Group
WLDN
$1.04B
| $476K | ﹤0.01% |
13,524
+8,970
| +197% | +$334K |
|
3208
CNA Financial
CNA
$14.2B
| $472K | ﹤0.01% |
10,716
-35,524
| -77% | -$1.58M |
|
3209
Select Water Solutions
WTTR
$2.3B
| $472K | ﹤0.01% |
75,857
+50,646
| +201% | +$315K |
|
3210
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.12B
| $471K | ﹤0.01% |
2,085
-76,918
| -97% | -$18.2M |
|
3211
Spero Therapeutics
SPRO
$67.7M
| $470K | ﹤0.01% |
29,371
+19,406
| +195% | +$308K |
|
|
AY
3212
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $470K | ﹤0.01% |
13,129
-9,948
| -43% | -$373K |
|
3213
FRP Holdings
FRPH
$428M
| $469K | ﹤0.01% |
16,222
+9,020
| +125% | +$259K |
|
3214
Oil States International
OIS
$488M
| $469K | ﹤0.01% |
94,391
+25,766
| +38% | +$152K |
|
3215
Blue Ridge Bankshares
BRBS
$315M
| $468K | ﹤0.01% |
26,129
+13,966
| +115% | +$254K |
|
|
CURO
3216
DELISTED
CURO Group Holdings Corp.
CURO
| $467K | ﹤0.01% |
29,189
+15,670
| +116% | +$273K |
|
3217
Sierra Bancorp
BSRR
$528M
| $463K | ﹤0.01% |
17,044
+11,305
| +197% | +$292K |
|
3218
MediciNova
MNOV
$65.5M
| $463K | ﹤0.01% |
172,800
+18,784
| +12% | +$62.8K |
|
3219
Rayonier Advanced Materials
RYAM
$604M
| $462K | ﹤0.01% |
80,870
+30,751
| +61% | +$200K |
|
3220
Sunoco
SUN
$14.4B
| $462K | ﹤0.01% |
11,339
+166
| +1% | +$6.58K |
|
3221
Red Robin
RRGB
$145M
| $461K | ﹤0.01% |
27,910
+6,729
| +32% | +$129K |
|
3222
Veru
VERU
$36M
| $461K | ﹤0.01% |
7,818
+5,186
| +197% | +$397K |
|
3223
PUT
Veeva Systems
VEEV
$33.1B
| $460K | ﹤0.01% |
1,800
| – | – |
|
3224
VistaGen Therapeutics
VTGN
$9.89M
| $459K | ﹤0.01% |
7,850
+5,203
| +197% | +$339K |
|
3225
Artesian Resources
ARTNA
$355M
| $458K | ﹤0.01% |
9,881
+6,554
| +197% | +$275K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.